首页> 美国卫生研究院文献>Scientific Reports >64Cu and fluorescein labeled anti-miRNA peptide nucleic acids for the detection of miRNA expression in living cells
【2h】

64Cu and fluorescein labeled anti-miRNA peptide nucleic acids for the detection of miRNA expression in living cells

机译:用于检测活细胞中miRNA表达的64Cu和荧光素标记的抗miRNA肽核酸

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

MiRNAs are single stranded RNAs of 18–22 nucleotides. They are promising diagnostic and prognostic markers for several pathologies including tumors, neurodegenerative, cardiovascular and autoimmune diseases. In the present work the development and characterization of anti-miRNA radiolabeled probes based on peptide nucleic acids (PNAs) for potential non-invasive molecular imaging in vivo of giant cell arteritis are described. MiR-146a and miR-146b-5p were selected as targets because they have been found up-regulated in this disease. Anti-miR and scramble PNAs were synthesized and linked to carboxyfluorescein or DOTA. DOTA-anti-miR PNAs were then labelled with copper-64 (64Cu) to function as non-invasive molecular imaging tools. The affinity of the probes for the targets was assessed in vitro by circular dichroism and melting temperature. Differential uptake of fluorescein and 64Cu labeled anti-miRNA probes was tested on BCPAP and A549 cell lines, expressing different levels of miR-146a and -146b-5p. The experiments showed that the anti-miR-146a PNAs were more effective than the anti-miR-146b-5p PNAs. Anti-miR-146a PNAs could bind both miR-146a and miR-146b-5p. The uptake of fluorescein and 64Cu labeled anti-miR-146a PNAs was higher than that of the negative control scramble PNAs in miRNA expressing cells in vitro. 64Cu-anti-miR-146a PNAs might be further investigated for non-invasive PET imaging of miR-146 overexpressing diseases.
机译:MiRNA是18-22个核苷酸的单链RNA。它们是包括肿瘤,神经退行性疾病,心血管疾病和自身免疫性疾病在内的多种病理学的有前景的诊断和预后标志物。在本工作中,描述了基于肽核酸(PNA)的抗miRNA放射性标记探针的开发和表征,该探针可用于体内巨细胞动脉炎的潜在非侵入性分子成像。选择了MiR-146a和miR-146b-5p作为靶标,因为已发现它们在该疾病中上调。合成了抗miR和加扰的PNA,并将其与羧基荧光素或DOTA连接。然后用铜64( 64 Cu)标记DOTA-抗miR PNA,以用作非侵入性分子成像工具。通过圆二色性和解链温度在体外评估探针对靶标的亲和力。在BCPAP和A549细胞系上测试了荧光素和 64 Cu标记的抗miRNA探针的差异摄取,表达了不同水平的miR-146a和-146b-5p。实验表明,抗miR-146a PNA比抗miR-146b-5p PNA更有效。抗miR-146a PNA可以结合miR-146a和miR-146b-5p。在体外表达miRNA的细胞中,荧光素和 64 Cu标记的抗miR-146a PNA的摄取高于阴性对照的PNA。可能需要进一步研究 64 Cu-anti-miR-146a PNAs对miR-146过表达疾病的无创PET成像。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号